Annual Report 2025

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2025 92 The United Laboratories International Holdings Limited Annual Report 2025 6. OTHER INCOME 2025 2024 RMB’000 RMB’000 Bank interest income 152,573 127,791 Sales of scrap materials 37,585 31,654 Subsidy income (Note) 155,855 189,626 Sundry income 8,354 7,858 354,367 356,929 Note: Subsidy income includes tax subsidy and grants from the PRC government which are specifically for (i) capital expenditure incurred for plant and machinery, which are recognised as income over the useful life of related assets; (ii) incentives and other subsidies for research and development activities, which are recognised upon meeting the specific conditions; and (iii) incentives which have no specific conditions attached to the grants. Details of the subsidy income are set out in Note 33. 7. OTHER GAINS AND LOSSES, NET 2025 2024 RMB’000 RMB’000 Other gains and losses, net Net gain on fair value changes of derivative financial instruments (Note) 133,658 92,032 Gain on disposal of financial assets at FVTPL 79,378 66,501 Net gain (loss) on disposal of property, plant and equipment 21,036 (4,269) Written off of property, plant and equipment (48,585) (23,297) Net foreign exchange (loss) gain (161,393) 25,792 Others (723) (2,978) 23,371 153,781 Note: During the years ended 31 December 2025 and 2024, the Group had entered into several foreign currency forward contracts with banks and financial institutions to reduce its exposure to foreign currency risks. These derivatives were not accounted for under hedge accounting. The Group did not hold any (2024: nil) derivative financial instruments as at 31 December 2025.